Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/02/063274
CTRI/2024/02/063274
Not yet recruiting
Phase 3

Comparison of efficacy and safety profile of oral Cyclosporine vs oral Methotrexate in the management of severe paediatric atopic dermatitis – a randomized controlled trial - NI

IMS and SUM Hospital0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
IMS and SUM Hospital
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
IMS and SUM Hospital

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients with severe AD
  • •2\. EASI more than 21
  • •3\. Objective SCORAD more than 40
  • •4\. Chronic relapsing eczema for more than 3months

Exclusion Criteria

  • •1\. Patients with deranged liver function test (LFT)
  • •2\. Patients with deranged renal function test (RFT)
  • •3\. Patients with deranged Complete Blood Counts (CBC)
  • •4\. Known case of cardiac disease
  • •5\. Known case of hypertension
  • •6\. Known case of chronic or recurrent infections
  • •7\. Known case / family or contact history of tuberculosis
  • •8\. Known case of immunodeficiency syndrome
  • •9\. Known case of malignancy
  • •10\. Patients with known hypersensitivity to cyclosporine and methotrexate

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Effectiveness and safety of oral and intralesional tranexamic acid in treatment of melasmaHealth Condition 1: L811- ChloasmaHealth Condition 2: O- Medical and Surgical
CTRI/2021/08/035350Department of Dermatology42
Not yet recruiting
Not Applicable
To observe the efficacy of oral fluconazole versus 5% amrolfine nail lacquer in the patients of Onychomycosis.Health Condition 1: L609- Nail disorder, unspecified
CTRI/2020/12/029904Dr Ruchir M Bhatt
Completed
Phase 4
The evaluation of the efficacy and safety of oral fingolimod in relapsing remitting multiple sclerosismultiple sclerosis.Disseminated Multiple Sclerosis
IRCT201406018323N10Vice-chancellor for research, Kermanshah University of Medical Sciences60
Not yet recruiting
Phase 4
A study to compare efficacy and safety of levocetrizine versus levocetrizine alongwith probiotic in allergic rhinitis patientHealth Condition 1: J309- Allergic rhinitis, unspecified
CTRI/2023/11/059620Shujauddin
Not yet recruiting
Phase 2
Research on Cheep (Pityriasis Versicolor) in Unani medicineHealth Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
CTRI/2023/06/053546ational Institute of Unani Medicine